ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

GRF Eagle Capital Growth Fund Inc

9.3503
0.0503 (0.54%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Eagle Capital Growth Fund Inc GRF AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0503 0.54% 9.3503 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
9.385 9.3503 9.385 9.3503 9.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202408:30GLOBEGrifols Celebrates 50 Years of Manufacturing Life-Changing..
04/4/202403:00GLOBEGrifols Procleix ArboPlex Assay® Receives CE Mark, the First..
07/3/202410:11EDGAR2Form DEF 14A - Other definitive proxy statements
06/3/202411:56EDGAR2Form N-CSR - Certified Shareholder Report
28/2/202410:20EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
23/2/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:16GLOBEGrifols announces positive topline phase 3 fibrinogen..
13/2/202414:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202307:00GLOBEGrifols Completes Cohort 1 in Clinical Study of Alpha-1 15%,..
07/11/202315:45EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
06/11/202307:00GLOBEGigaGen Presents IND-Enabling Data and Phase 1 Trial..
24/10/202317:30GLOBEAraclon Biotech Presents Positive Final Results from Phase 2..
13/10/202316:30BWEagle Capital Growth Fund Declares Year-End Distribution of..
02/10/202313:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
02/10/202313:16EDGAR2Form SC 13D/A - General statement of acquisition of..
30/8/202314:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202314:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202314:45EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
01/8/202307:00GLOBEGrifols Accelerates Healthcare Innovation with Google..

Su Consulta Reciente

Delayed Upgrade Clock